Flavanol metabolites reduce monocyte adhesion to endothelial cells through modulation of expression of genes via p38-MAPK and p65-Nf-kB pathways

Molecular Nutrition and Food Research

Volumn 58, Issue 5, 2014, Pages 1016-1027

  Claude, Sylvain ^a,b   Boby, Celine ^c   Rodriguez Mateos, Ana ^d   Spencer, Jeremy P E ^d   Gérard, Nicolas ^a,b   Morand, Christine ^a,b   Milenkovic, Dragan ^a,b  

^a CRNH AUVERGNE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UMR1213 HERBIVORES   (France)

^d UNIVERSITY OF READING   (United Kingdom)

Author keywords

Endothelial cells; Flavanol metabolites; Gene expression; Monocyte adhesion

Indexed keywords

CATECHIN; EPICATECHIN SULFATE; FLAVONOL DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; SULFATE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANALOGS AND DERIVATIVES; CELL ADHESION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; MONOCYTE; NUTRIGENOMICS; PHOSPHORYLATION; PROCEDURES; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

CATECHIN; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLAVONOLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MONOCYTES; NUTRIGENOMICS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SULFURIC ACID ESTERS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898952581     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300658     Document Type: Article

References (43)

1. Gu, L., Kelm, M. A., Hammerstone, J. F., Beecher, G. et al., Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J. Nutr. 2004, 134, 613-617.
2. Fraga, C. G., Oteiza, P. I., Dietary flavonoids: Role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 2011, 51, 813-823.
3. Ottaviani, J. I., Momma, T. Y., Heiss, C., Kwik-Uribe, C. et al., The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic. Biol. Med. 2011, 50, 237-244.
4. Manach, C., Williamson, G., Morand, C., Scalbert, A., Remesy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
5. Actis-Goretta, L., Leveques, A., Giuffrida, F., Romanov-Michailidis, F. et al., Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 2012, 53, 787-795.
6. Buijsse, B., Weikert, C., Drogan, D., Bergmann, M. et al., Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur. Heart J. 2010, 31, 1616-1623.
7. Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L. et al., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895-909.
8. Gu, Y., Lambert, J. D., Modulation of metabolic syndrome-related inflammation by cocoa. Mol. Nutr. Food Res. 2013, 57, 948-961.
9. Arranz, S., Valderas-Martinez, P., Chiva-Blanch, G., Casas, R. et al., Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans. Mol. Nutr. Food Res. 2013, 57, 936-947.
10. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38-50.
11. Fraga, C. G., Litterio, M. C., Prince, P. D., Calabro, V. et al., Cocoa flavanols: effects on vascular nitric oxide and blood pressure. J. Clin. Biochem. Nutr. 2011, 48, 63-67.
12. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P. et al., (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 2006, 103, 1024-1029.
13. Auclair, S., Milenkovic, D., Besson, C., Chauvet, S. et al., Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 2009, 204, e21-e27.
14. Norata, G. D., Marchesi, P., Passamonti, S., Pirillo, A. et al., Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007, 191, 265-271.
15. Koga, T., Meydani, M., Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr. 2001, 73, 941-948.
16. Vazquez-Agell, M., Urpi-Sarda, M., Sacanella, E., Camino-Lopez, S. et al., Cocoa consumption reduces NF-kappaB activation in peripheral blood mononuclear cells in humans. Nutr. Metab. Cardiovasc Dis. 2013, 23, 257-263.
17. Mulla, E. S., Van Zandta, M., Golebiowskia, A., Becketta, R. P., et al., A versatile approach to the regioselective synthesis of diverse (-)-epicatechin-β-d-glucuronides. Tetrahedron Lett. 2012, 53, 1501-1503.
18. Zhang, M., Jagdmann, G. E., Jr, Van Zandt, M., Sheeler, R., et al., Chemical synthesis and characterization of epicatechin glucuronides and sulfates: bioanalytical standards for epicatechin metabolite identification. J. Nat. Prod. 2013, 2, 157-169.
19. Sharma, P. K., He, M., Jurayj, J., Gou, D. M. et al., Enantioselective syntheses of sulfur analogues of flavan-3-Ols. Molecules 2010, 8, 5595-5619.
20. Rodriguez-Mateos, A., Oruna-Concha, M. J., Kwik-Uribe, C., Vidal, A. et al., Influence of sugar type on the bioavailability of cocoa flavanols. Br. J. Nutr. 2012, 108, 2243-2250.
21. Libby, P., Ridker, P. M., Hansson, G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473, 317-325.
22. Perrot-Applanat, M., Vacher, S., Toullec, A., Pelaez, I. et al., Similar NF-kappaB gene signatures in TNF-alpha treated human endothelial cells and breast tumor biopsies. PLoS One 2011, 6, e21589.
23. Mullen, W., Borges, G., Donovan, J. L., Edwards, C. A. et al., Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am. J. Clin. Nutr. 2009, 89, 1784-1791.
24. Tomas-Barberan, F. A., Cienfuegos-Jovellanos, E., Marin, A., Muguerza, B. et al., A new process to develop a cocoa powder with higher flavonoid monomer content and enhanced bioavailability in healthy humans. J. Agric. Food. Chem. 2007, 55, 3926-3935.
25. Schnorr, O., Brossette, T., Momma, T. Y., Kleinbongard, P. et al., Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch. Biochem. Biophys. 2008, 476, 211-215.
26. Schroeter, H., Bahia, P., Spencer, J. P., Sheppard, O. et al., (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J. Neurochem. 2007, 101, 1596-1606.
27. Vauzour, D., Vafeiadou, K., Rice-Evans, C., Williams, R. J. et al., Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 4, 1355-1367.
28. Spencer, J. P., Rice-Evans, C., Williams, R. J., Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem. 2003, 37, 34783-3493.
29. Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L. et al., Structural determinantsof phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 2000, 6, 909-919.
30. Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C. et al., Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 11, 1649-1657.
31. Balzer, J., Rassaf, T., Heiss, C., Kleinbongard, P. et al., Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol. 2008, 51, 2141-2149.
32. Schewe, T., Steffen, Y., Sies, H., How do dietary flavanols improve vascular function? A position paper. Arch. Biochem. Biophys. 2008, 476, 102-106.
33. Libby, P., Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2045-2051.
34. Jeong, Y. J., Choi, Y. J., Kwon, H. M., Kang, S. W. et al., Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr. 2005, 93, 581-591.
35. Ludwig, A., Lorenz, M., Grimbo, N., Steinle, F. et al., The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun. 2004, 316, 659-665.
36. Keiper, T., Al-Fakhri, N., Chavakis, E., Athanasopoulos, A. N. et al., The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J. 2005, 19, 2078-2080.
37. van Buul, J. D., Hordijk, P. L., Signaling in leukocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 824-833.
38. Barreiro, O., Yanez-Mo, M., Serrador, J. M., Montoya, M. C. et al., Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J. Cell Biol. 2002, 157, 1233-1245.
39. Lusis, A. J., Atherosclerosis. Nature 2000, 407, 233-241.
40. Jacobson, J. R., Dudek, S. M., Birukov, K. G., Ye, S. Q. et al., Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am. J. Respir. Cell Mol. Biol. 2004, 30, 662-670.
41. Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I. et al., Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008, 8, 372-383.
42. Usatyuk, P. V., Natarajan, V., Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J. Biol. Chem. 2004, 279, 11789-11797.
43. Vafeiadou, K., Vauzour, D., Lee, H. Y., Rodriguez-Mateos, A. et al., The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484, 100-109.